Spero Therapeutics Inc (SPRO) — Financial Flexibility Index
Spero Therapeutics Inc (SPRO) has a Financial Flexibility Index of -0.84x as of December 2025. Free cash flow of $-8.35 Million (operating CF $-8.35 Million minus capex $0.00) represents -1% of total liabilities ($9.90 Million). Check total reinvestment intensity of Spero Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Spero Therapeutics Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Spero Therapeutics Inc across 11 annual periods. For the full cash flow conversion analysis, see Spero Therapeutics Inc (SPRO) cash flow conversion.
Annual Financial Flexibility Index for Spero Therapeutics Inc (2015–2025)
Year-by-year free cash flow to debt coverage for Spero Therapeutics Inc. Explore cash flow to debt ratio of Spero Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.28x | $-12.62 Million | $-12.62 Million | $9.90 Million | ▼ -250.5% |
| 2024 | -0.36x | $-23.44 Million | $-23.44 Million | $64.42 Million | ▲ +16.7% |
| 2023 | -0.44x | $-32.99 Million | $-32.99 Million | $75.50 Million | ▼ -176.3% |
| 2022 | -0.16x | $-7.73 Million | $-7.73 Million | $48.87 Million | — |
| 2021 | 0.00x | $0.00 | $-64.35 Million | $82.78 Million | ▲ +100.0% |
| 2020 | -4.00x | $-85.72 Million | $-85.87 Million | $21.41 Million | ▼ -153.9% |
| 2019 | -1.58x | $-49.71 Million | $-50.02 Million | $31.53 Million | ▲ +44.3% |
| 2018 | -2.83x | $-37.19 Million | $-39.62 Million | $13.15 Million | ▲ +38.3% |
| 2017 | -4.59x | $-39.08 Million | $-39.11 Million | $8.52 Million | ▼ -20.8% |
| 2016 | -3.80x | $-28.13 Million | $-28.96 Million | $7.41 Million | ▼ -200.9% |
| 2015 | -1.26x | $-9.38 Million | $-9.61 Million | $7.43 Million | — |